What is the recommended dosage of bromhexine for a patient with chronic kidney disease (CKD) stage 5 undergoing hemodialysis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 25, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Bromhexine Dosing in CKD Stage 5 on Hemodialysis

I cannot provide a specific dosage recommendation for bromhexine in patients with CKD stage 5 on hemodialysis because the provided evidence does not contain any information about bromhexine dosing, pharmacokinetics, or use in renal impairment.

Critical Gap in Evidence

  • The evidence provided includes guidelines for various medications in renal disease (antidiabetic agents, antibiotics, antituberculosis drugs, anticoagulants) but no information specific to bromhexine exists in these sources 1.

  • General principles for drug dosing in hemodialysis patients emphasize that renal dysfunction alters drug pharmacokinetics through reduced glomerular filtration, altered tubular secretion, and changes in drug metabolism 2, 3.

  • Hemodialysis patients experience both decreased renal drug excretion and substantially decreased nonrenal clearance, placing them at increased risk for drug accumulation and adverse events 3, 4.

Recommended Approach

You must verify bromhexine's specific dosing information from the manufacturer's prescribing information or package insert before administering this medication to a hemodialysis patient 5.

  • Contact the prescribing physician or pharmacist who can access the specific product information to ensure patient safety 5.

  • Check local formularies or drug databases for region-specific bromhexine formulations and their official dosing guidelines 5.

  • Do not administer bromhexine without verified dosing information from official sources, as this poses significant risk of patient harm in the setting of severe renal impairment 5.

General Principles for Renal Dosing (When Information Becomes Available)

  • For medications cleared renally in hemodialysis patients, typical adjustments include reducing the dose, extending the dosing interval, or both methods simultaneously 2.

  • Medications should generally be administered after hemodialysis sessions to facilitate directly observed therapy and avoid premature drug removal 1.

  • Serum drug concentration monitoring should be considered when available to ensure adequate absorption without excessive accumulation 1, 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Drug dosing in chronic kidney disease.

The Medical clinics of North America, 2005

Research

Pharmacokinetic considerations in chronic kidney disease and patients requiring dialysis.

Expert opinion on drug metabolism & toxicology, 2014

Research

Clinical Pharmacokinetics in Kidney Disease: Fundamental Principles.

Clinical journal of the American Society of Nephrology : CJASN, 2018

Guideline

Medication Dosing Information

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What are the drug dosing recommendations for Reflex (unknown medication) in patients with Chronic Kidney Disease (CKD)?
What is the recommended treatment duration of Itopride (Nitzatidine) 50mg three times a day for a patient with Chronic Kidney Disease (CKD)?
Can prolog be given to someone with Chronic Kidney Disease (CKD)?
What is the recommended dosage of Ambroxol (mucolytic agent) for a patient with chronic kidney disease (CKD) stage 5 undergoing hemodialysis?
Is astaxanthin supplementation safe for a patient with Chronic Kidney Disease (CKD) undergoing hemodialysis, with comorbidities such as hypertension and diabetes?
How can a patient with suspected uncomplicated pericarditis (inflammation of the pericardium) test for the condition at home?
Is piperacillin-tazobactam (Pip/Taz) as effective as imipenem in treating Fournier's gangrene in a patient with a poor response to initial antibiotic therapy with ceftriaxone and metronidazole?
When should Continuous Positive Airway Pressure (CPAP) therapy be advised for a patient with mild Obstructive Sleep Apnea (OSA) and an Apnea-Hypopnea Index (AHI) of 7.6?
What is the appropriate management for an elderly female patient with newly diagnosed diabetes, presenting with high-grade fever and chills, who has been treated with IV Meropenem, has ECG changes suggestive of cardiac ischemia, and has now been diagnosed with dengue fever, alongside potential cardiac complications and hematological abnormalities?
What is the recommended dosage of Ambroxol (mucolytic agent) for a patient with chronic kidney disease (CKD) stage 5 undergoing hemodialysis?
How to manage a 45-year-old female with newly diagnosed Type II diabetes, recent urinary tract infection (UTI) treated with antibiotics (e.g. ceftriaxone or fluoroquinolone), presenting with uncontrolled diabetes (hyperglycemia), right kidney pyelonephritis, and mild left ventricular dysfunction (ejection fraction of 45%)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.